Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
